| Serial Number | 98283194 |
| Word Mark | CEDNEVY |
| Filing Date | Thursday, November 23, 2023 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Wednesday, May 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of The mark consists of CEDNEVY with fading circles to the left of the letter C. |
| Goods and Services | Pharmaceutical preparations for the treatment of parkinsons disease |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 16, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mitsubishi Tanabe Pharma Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chuo-ku, Osaka-shi Osa 541-8505 JP |
| Event Date | Event Description |
| Monday, November 27, 2023 | NEW APPLICATION ENTERED |
| Tuesday, January 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 5, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 17, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, May 21, 2024 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Wednesday, May 29, 2024 | ABANDONMENT - EXPRESS MAILED |
| Wednesday, May 29, 2024 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
| Wednesday, March 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 6, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 6, 2024 | NON-FINAL ACTION E-MAILED |